Lifnano Therapeutics

Nanoengineering platform to deliver Leukaemia Inhibitory Factor (LIF)

placeCambridge, England, United Kingdom calendar_todayFounded 2013 groups2 employees language lifnano.com

Registered entities

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon